HGI
GMAB icon

Hansberger Growth Investors’s Genmab GMAB Stock Holding History

Hansberger Growth Investors’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$2.56M Sell
69,915
-23,091
-25% -$835K 2.9% 18
2020
Q2 		$3.15M Sell
93,006
-55,745
-37% -$1.52M 3.79% 14
2020
Q1 		$3.15M Sell
148,751
-7,848
-5% -$175K 4.25% 12
2019
Q4 		$3.5M Buy
+156,599
New +$3.42M 3.94% 12

Other funds holding GMAB

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Hansberger Growth Investors's GMAB Position: Q3 2020 in Review

Hansberger Growth Investors reduced its Genmab (GMAB) stake by 25% in Q3 2020, selling an estimated $835K and leaving 69,915 shares worth $2.56M. The position accounts for 2.9% of the portfolio, ranked #18.

Hansberger Growth Investors first reported a position in GMAB in Q4 2019 and has held it in 4 quarters since. The position peaked at $3.5M in Q4 2019. 199 funds tracked by Wall St. Rank hold GMAB as of Q3 2020.

  • Hansberger Growth Investors held 69,915 shares of Genmab worth $2.56M as of Q3 2020.
  • Hansberger Growth Investors sold 23,091 Genmab shares in Q3 2020, an estimated $835K.
  • Genmab made up 2.9% of Hansberger Growth Investors's portfolio in Q3 2020, its #18 holding.
  • Hansberger Growth Investors first reported a position in Genmab in Q4 2019 and has held it in 4 quarters since.
  • Hansberger Growth Investors's Genmab position peaked at $3.5M in Q4 2019.
  • 199 funds tracked by Wall St. Rank held Genmab as of Q3 2020.

Based on Hansberger Growth Investors's 13F filing for Q3 2020, filed 12 Nov 2020.